ChemAnalyst

Executive Summary The  Amphotericin B Prices  witnessed a modest yet steady upward movement across key global markets during the quarter ending December 2025. The global antifungal pharmaceutical segment continued to experience constrained supply conditions, firm procurement patterns, and ongoing logistics pressures. Across North America, Asia-Pacific (APAC), and Europe, the Amphotericin B Price Index recorded quarterly increases ranging between 0.51% and 0.56%, indicating ti

Executive Summary The global Amphotericin B market experienced modest but significant upward pricing momentum during the quarter ending September 2025. Across all three major regions—North America, Asia-Pacific (APAC), and Europe—prices increased slightly, largely driven by frontloading activities, logistical pressures, and mild improvements in export demand. With a narrow market structure characterized by limited suppliers, stringent manufacturing requirements, and tightly m